Stocktoria

BeOne Medicines Ltd. ONC

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-02
Chart by TradingView
7/9
Piotroski F — financial health
1.78
Altman Z″ — distress risk · grey
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$5.3B$3.8B$2.5B$1.4B$1.2B
Gross profit$4.7B$3.2B$2.1B$1.1B$1.0B
Operating income$447.1M-$568.2M-$1.2B-$1.8B-$1.4B
Net income$286.9M-$644.8M-$881.7M-$2.0B-$1.5B
Operating cash flow$1.1B-$140.6M-$1.2B-$1.5B-$1.3B
Free cash flow$941.7M-$633.3M-$1.7B-$1.8B-$1.6B
Total assets$8.2B$5.9B$5.8B$6.4B$8.5B
Total liabilities$3.8B$2.6B$2.3B$2.0B$2.4B
Shareholders' equity$4.4B$3.3B$3.5B$4.4B$6.1B
Ratios
Gross margin87.5%84.4%84.5%79.8%86.0%
Operating margin8.4%-14.9%-49.1%-126.4%-122.3%
Net margin5.4%-16.9%-35.9%-141.5%-123.9%
FCF margin17.6%-16.6%-69.9%-128.7%-132.8%
Return on assets3.5%-10.9%-15.2%-31.4%-17.1%
Return on equity6.6%-19.4%-24.9%-45.7%-23.8%
Debt / equity0.19×0.05×0.06×0.05×0.03×
Current ratio3.411.802.323.554.76
Revenue growth40.2%55.0%73.7%20.4%280.8%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC65,456$19.4M

Why these scores methodology →

Piotroski F-score: 7/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 1.78 (grey)

  • Working capital / assets 0.538
  • Retained earnings / assets -1.016
  • EBIT / assets 0.055
  • Equity / liabilities 1.139

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001651308 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.